This is consistent with our findings where cytoglobin expression in p53-wildtype oral cancer cells treated with cisplatin leads to increased G1 arrest, enhanced Chk1 and p21 induction, and resistance to apoptosis. This evidence concerns the gene TP53 and lip and oral cavity carcinoma.